Identity
Protein

Description
Tuberin; 1807 amino acids; 190 kDaltons.
Expression
Expressed in most embryonic and adult tissues.
Localisation
Cytoplasmic
Function
Potential GTPase activating protein (GAP) for Rap1a and/or Rab5; Interacts with hamartin (TSC1 gene product) and Homology 188 residues at the COOH terminus have homology to Rap/Ran GAP.
Mutations
Germinal
Large genomic deletions in <10% of cases; point mutations widely dispersed, with no cluster; truncating effect in 2/3 of cases. 
Implicated in
Tuberous Sclerosis Comples (TSC)
Disease Autosomal dominant disease characterized by seizures, mental retardation, autism, benign tumors of the brain, heart, skin, kidney, and malignant kidney tumors.
Sporadic lymphangioleiomyomatosis (LAM)
Disease Lung disease affecting almost exclusively women, characterized by diffuse bilateral proliferation of abnormal smooth muscle cells in the lungs.
References
The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993 Dec 31;75(7):1305-15 Carbonara C, Longa L, Grosso E, Borrone C, Garrè MG, Brisigotti M, Migone N. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressorlike activity also for the TSC1 gene. Hum Mol Genet. 1994 Oct; 3(10):1829-32 Green AJ, Smith M, Yates JR. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet. 1994 Feb; 6(2):193-6 Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in TSC2 (tuberous sclerosis 2) Astrinidis A, Petri Henske E Atlas Genet Cytogenet Oncol Haematol. 2002; 6(1) 
